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abstract
introduction. Wide spectrum of alterations associated with highly active antiretroviral therapy (HAART) has 
been reported. The current study aimed at evaluating the role of Hypoxis hemerocallidea (HH) aqueous extract 
on the testosterone levels, expression of androgen receptors and collagen fibers in the testes of streptozotocin- 
-nicotinamide-induced diabetic rats under HAART regimen.
Material and methods. Sixty two adult male Sprague-Dawley rats (189.0 ± 4.5 g) were divided into eight groups 
(8 animals in each treatment groups and 6 rats in the control group). Diabetes was induced by a single intraperi-
toneal injection of nicotinamide (110 mg/kg bw) followed by streptozotocin (45 mg/kg bw) and the animals were 
then subjected to various treatments with HAART, HH extract or melatonin. At the end of the experiment, 
blood samples were collected to measure serum testosterone levels. Testes were fixed in buffered formaldehyde 
and paraffin processed. The expression of androgen receptor (AR) was assessed by immunohistochemistry and 
collagen fibers were visualized by Masson trichrome staining. 
results. Serum testosterone level was drastically (p < 0.0001) reduced in all rats with induced diabetes. In the 
testis of diabetic rats increased collagen fibers deposition with varying derangements in germinal epithelium of 
spermatogenic layers were observed. Intertubular hemorrhages and absence of spermatozoa were also noted in the 
testes of diabetic rats subjected to HAART. Reduced immunoexpression of ARs was found in the nuclei of Sertoli 
cells and the cytoplasm of spermatogonia and spermatocytes in III–IV stages of the seminiferous epithelium cycle 
of diabetic animals treated with different dosages of HH alone and those treated with HAART concomitantly with 
melatonin and HH. The expression of ARs was almost negative in the testes of rats treated with HAART alone. 
Conclusions. Concomitant treatment of rats with aqueous HH extract during the HAART did not change se-
rum testosterone level nor mitigate the altered expression of collagen fibers and androgen receptor resulting 
from STZ-nicotinamide-induced diabetes. Therefore, anti-diabetic properties of Hypoxis extract require further 
investigation. (Folia Histochemica et Cytobiologica 2017, Vol. 55, No. 3, 149–158)
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The incidence and prevalence of diabetes co-mor-
bidity in people living with human immunodeficiency 
virus (HIV) and acquired immune deficiency syn-
drome (AIDS) (PLWHAs) is becoming alarming in 
the populace. A total of 1,724 cases of diabetes were 
identified among 41,068 PLWHAs [1]. The reported 
prevalence rates ranged from 2.85% to 14.9% [2]. The 
high level of variability in the reported incidence and 
prevalence rates of diabetes co-morbidity observed [3] 
is paralleled by a wide spectrum of metabolic alter-
ations associated with highly active antiretroviral 
therapy (HAART). This includes changes in glucose 
homeostasis and fat redistribution [4, 5] even in the 
face of enhanced quality of life outcomes associated 
with HAART [6].
The involvement of HIV and HAART in inducing 
endocrine or metabolic dysfunction has been report-
ed [7] with consequential increase in morbidity and 
mortality due to cardiovascular diseases [8]. HIV in-
fection, especially in the advanced stages, is associated 
with an augmented and sustained pro-inflammatory 
state. It activates macrophages to actively secrete 
pro-inflammatory cytokines like tumor necrosis fac-
tor-a (TNF-a) and interleukin-1 (IL-1) [9]. These 
cytokines cause an alteration in the hypothalamus-pi-
tuitary-adrenal/thyroid/gonadal axes, which directly 
affects hormonal secretion at the cellular level [10]. 
The strongest relationship with diabetes was exposure 
to stavudine, while treatment with zidovudine and 
didanosine were also associated with an increased 
risk of diabetes [11, 12]. This constellation of abnor-
malities called antiretroviral-associated diabetes is 
consistent with the clinical picture of type 2 diabetes 
mellitus (T2DM), rather than type 1 diabetes mellitus 
(T1DM) [13].
Diabetes mellitus (DM) is mainly presented with 
hyperglycemia, consequent of defects in insulin se-
cretion, insulin action, or both. The most prevalent 
form of DM is T2DM, comprising up to 95% of all 
diagnosed diabetic individuals [14]. T2DM induces 
metabolic alterations, disrupting the endocrine sys-
tem, with a subsequent dysfunction of the hypothal-
amus-pituitary-testicles (HPT) axis [15]. This may 
result in impairment of the male reproductive health. 
Although not all diabetic men are infertile, evidences 
strongly associate T2DM with high prevalence of male 
subfertility/infertility [16] with associated reduction in 
birth rates [17]. Consequently, the disturbing increase 
in the number of diabetic men in reproductive age as 
well as the multiple molecular mechanisms and path-
ways that are affected by DM with substantial effects 
on male reproductive function [18, 19].
The testes comprises of heterogeneous cell pop-
ulation, including somatic and germ cells. Testicular 
cells present unique metabolic characteristics, in part 
due to the existence of the blood-testis barrier. The 
Sertoli cells (SCs) are responsible for the production 
of metabolic precursors essential for germ cells de-
velopment [20]. These cells show a “Warburg-like 
effect” metabolism [21], using the external glucose 
to produce lactate, which is the preferred substrate 
of developing germ cells [22].
The main function of the testis is the production 
of spermatozoa in the process of spermatogenesis. 
This complex process is precisely regulated by andro-
gens, although, estrogens have also been shown to be 
involved [23, 24]. Androgens are steroid hormones 
primarily involved in the establishment of sexual 
maturation at puberty, and in maintenance of the 
male reproductive function, spermatogenesis and 
sexual behavior during adult life [25]. Many studies 
have proved that not only androgens have important 
functions in the adult male reproductive organ, but 
also estrogen and its receptors are essential for normal 
fertility in the male. Androgen and estrogen exert 
their cellular effects via steroid receptors (ARs and 
ERs, respectively) of the nuclear receptor superfamily 
and act as ligand-dependent transcription factors [26]. 
After the binding of androgens, ARs undergo a con-
formational change, dimerization, translocation to the 
cell nucleus and binding to specific DNA sequence, 
thus modulating expression of target genes [27].
Exogenous insulin and other medications can 
control many aspects of diabetes, numerous com-
plications affecting longevity and quality of life [28]. 
HIV/AIDS treatment nowadays includes chronic 
and metabolic complications of the disease, and the 
adverse effects associated with its treatments. The 
high cost of insulin and HAART-associated toxicities 
necessitates the need for safer and less demanding 
adjuvant. Plant-based adjuvant has the potential to 
fill this need. The search for herbal remedies has 
continued to grow due to its accessibility, relatively 
low cost and a perceived effectiveness. Consequently, 
there is wide spread of consumption of herbal prod-
ucts, including Hypoxis hemerocallidea (HH) for the 
management of HIV/AIDS either as complimentary 
or alternative medicine [29].
Hypoxis hemerocallidea (African potato) belongs to 
the genus of the family Hypoxidaceae [30] and is freely 
distributed in five provinces of South Africa, including 
KwaZulu-Natal. Anecdotal use of HH predates many 
generations [31] especially its traditional utilization 
for the treatment of various ailments related to the 
urogenital system [32]. However, the popularity of 
this plant rose tremendously following the increased 
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burden from the scourge of HIV/AIDS and its treat-
ment as PLWHAs relied upon the corm for immune 
boosting potentials. The Hypoxis corm is noted for 
the occurrence of a hypoxide (a powerful antioxidant 
component) which is a secondary metabolite of the 
plant [32] that is hydrolyzed into rooperol in the large 
intestine [33]. Pharmacokinetic studies have indicated 
that rooperol can be found in feces, and metabolites 
are found in the serum and urine as its glycosides, 
sulfates, mixed glucuronides and sulfuronides [29]. 
The glycoside has low toxicity and the corm containing 
it is also used as food [30] and has been well used for 
traditional and pharmaceutical purposes [31]. 
With increasing interest in the use of phytosterols, 
also a phytochemical component of Hypoxis, for the 
reduction of serum cholesterol and immune boost-
ing, there has been a resultant increase in scientific 
investigations [34] surrounding these benefits. This is 
paralleled by the accessibility of commercially availa-
ble herbal medicines containing sterols with Hypoxis 
extract enrichments claimed to be efficacious against 
a variety of diseases.
Studies from our laboratory [35], however, indicate 
that the perceived positive benefits of extracts from 
Hypoxis require further scientific investigations in 
view of the negative hepatotoxic indices emanating 
from our animal model. Whilst PLWHAs continue to 
patronize Hypoxis product for various reasons, there 
is a need to understand potential interactions and 
benefits following antiretroviral therapy in diabetic 
comorbid. Therefore, this study was designed to eval-
uate the effects of the Hypoxis hemerocallidea on the 
testis of streptozotocin-nicotinamide-induced diabetic 
rats through immunopathological study, using both 
androgen receptors and collagen fibers as indicators 
of the testicular integrity.
Material and methods
drugs and reagents. Nicotinamide, melatonin, lamivudine 
(3TC), zidovudine and nevirapine (Aspen) were purchased 
from Pharmed Ltd., Durban, South Africa. Monoclonal 
Anti-antibody kits (N-20, Santa Cruz Biotechnology, CA, 
USA), diaminobenzidine (DAB) and streptozotocin (Sig-
ma-Aldrich, St. Louis, MO, USA) of analytical grade quality 
were purchased from Capital Lab Supplies, Durban, South 
Africa. Glucose strips (Bayer Contour TS, Basel, Switzer-
land) was purchased from local pharmacy.
Collection of plant material. Fresh corms of Hypoxis hemero-
callidea were purchased from a local ‘Muthi’ in Umbilo 
Road, Durban, KwaZulu-Natal, between June and July, 
2014. The corms were authenticated at the Department of 
Life Science, Westville Campus, University of KwaZulu-Na-
tal, Durban, South Africa.
Extraction of Hypoxis hemerocallidea. Hypoxis fresh corms 
were extracted according to the procedure of Ojewole [36]. 
They were washed with water, cut into smaller pieces, air 
dried at room temperature (25–28°C) and ground into pow-
dered form in a commercial blender. The milled corm was 
soaked in hot distilled water and extracted twice, on each oc-
casion with 2.5 liters of hot distilled water (at 90–100°C) for 
12 hours. The combined extract soluble were concentrated 
to dryness under reduced pressure in a rotary evaporator at 
70 ± 1°C. The resulting crude aqueous extract was freeze-
dried, finally giving of a dark brown and powdery aqueous 
extract residue. Without any further purification, aliquot 
portions of the aqueous extract residue were weighed and 
dissolved in distilled water (at room temperature) for use 
on each day of our experiments.
animals. Sixty two adult male Sprague-Dawley rats aged 
9–10 weeks (189.0 ± 4.5 g, mean ± SEM) were used for 
this study. The animals were maintained at the Animal 
House of the Biomedical Resources Unit, University of 
KwaZulu-Natal. The animals received humane care in ac-
cordance with the Principle of Laboratory Animal Care of 
the National Medical Research Council and the Guide for 
the Care and Use of Laboratory Animals of the National 
Academy of Sciences (National Institute of Health Guide, 
1985). The study protocol was approved by the University 
of KwaZulu-Natal Animal Ethics Committee (Ethical clear-
ance number: 056/15/Animals). All the rats were housed 
in well ventilated plastic cages having dimensions of 36 cm 
long × 24 cm wide × 15 cm high. They were maintained 
under standardized animal house conditions (temperature: 
28–31°C; light: approximately 12 hours natural light per day) 
and were fed with standard rat pellets from (Meadow feeds, 
a Division of Astral Operations Limited, Durban, South 
Africa) and given tap water ad libitum.
Experimental design. Diabetic animals (n = 56) were distrib-
uted into seven treatment groups: B–H with eight animals 
per group and the control group (A, n = 6) and treatment 
was administered as follows: group A received water as pla-
cebo (negative control vs. diabetic rats); group B served as di-
abetic control (positive control); group C received HAART 
cocktail (zidovudine, lamivudine and nevirapine), using 
the human therapeutic dose equivalents (600 mg, 300 mg 
and 400 mg/day, respectively), as adjusted for animal 
weight to obtain corresponding therapeutic doses for the 
rat model [37]; group D received HH extract (100 mg/kg 
bw); group E received HH extract (200 mg/kg bw); group F 
received combined HAART cocktail and melatonin (5 mg/ 
/kg bw); group G received combined HAART cocktail and 
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HH extract (100 mg/kg bw) and group H received combined 
HAART cocktail and HH extract (200 mg/kg bw).
All substances were administered daily by oro-gastric 
gavage and the treatment lasted for 8 weeks.
induction of type 2 diabetes mellitus (t2d). To induce type 2 
diabetes mellitus animal model, rats were injected with 
single intraperitoneal dose of 110 mg/kg bw nicotinamide 
(Sigma-Aldrich) in physiological saline, and 15 minutes later, 
they were injected with 45 mg/kg bw of streptozotocin (Sig-
ma-Aldrich) dissolved in citrate buffer (pH 4.5) before intra-
peritoneal injection [38]. The control groups received vehicle 
citrate buffer through the same route. Seven days later, blood 
glucose concentrations in STZ-induced diabetic rats greater 
than 20 mmol/L were considered as indices of diabetes.
Body mass measurements. Body weight (BW) changes 
of the animals were weekly recorded. BW of the rats was 
recorded on the first day before the commencement of the 
treatment (the initial body weight), thereafter weekly and 
on the last day shortly before animal sacrifice (final body 
mass). Testis weights (LW) were measured by an electronic 
balance (Mettle Toledo; Microsep (Pty) Ltd, Greifensee, 
Switzerland) after laparotomy. Values are expressed in 
grams for all weight measurements.
Material collection and analysis. Eight weeks post-treatment, 
all animals were sacrificed by exposure to Halothane® for 
3 min via gas anesthetic chamber. Thereafter, blood samples 
were collected by cardiac puncture into pre-cooled heparin-
ized tubes and centrifuged in a desktop centrifuge model 90-1 
(Jiangsu Zhangji Instruments Co., Beijng, China) for 15 min 
at 3000 revolutions per minute. The serum was decanted into 
Eppendorf tubes and stored at –80°C for subsequent analysis. 
The testicles were excised, weighed and immediately fixed 
in 10% neutral-buffered formalin. After proper fixation, the 
tissues were dehydrated in graded series of alcohol, cleared 
in xylene and embedded in paraffin wax using a cassette.
histochemical examination of testes. Testes were sectioned 
at 5 µm thickness using Leica RM 2255 microtome and were 
stained with Masson trichrome (MT) for collagen fibers 
according to Drury and Wallington [39]. The stained slides 
were then coverslipped using DPX mounting glue directly 
over the tissue section, ensuring no air bubbles were trapped. 
Thereafter, the slides were left overnight to dry for examina-
tion under the light microscope. The sections were examined 
using a binocular microscope and image acquisition was 
done, using the Nikon Eclipse 80i (Nicon, Tokyo, Japan). 
An independent histopathologist blinded to the treatment 
groups reported on the qualitative assessments of the slides.
immunohistochemistry. The Avidin Biotin Complex (ABC) 
method was used. Androgen receptor (AR) was localized 
using rabbit anti-AR (N-20, Santa Cruz Biotechnology, 
CA, USA). Antigenic sites were retrieved using citric acid 
solution and pressure cooker. Peroxidases, protein and bi-
otin blocks were done using hydrogen peroxide, avidin and 
biotin, respectively. BRCA 1 and 2 antibodies were diluted 
1:100 and incubated on sections. These were followed by 
the biotinylated secondary antibody, streptavidin and DAB/ 
/substrate reaction according to Nasra [19]. 
In brief, formalin fixed and paraffin embedded tissues 
were sectioned on the rotary microtome and placed on the 
hot plate at 70°C for at least 1 hour. Sections were brought 
down to water by passing on 2 changes of xylene, then 
3 changes of descending grades of alcohol and finally to 
water. Antigen retrieval was performed on the sections 
by heating them on a citric acid solution of pH 6.0 using 
microwave at power 100 for 15 minutes. The sections were 
equilibrated gradually with cool water to displace the hot 
citric acid for at least 5 min for the section to cool. Peroxidase 
blockings were done on the sections by covering section with 
3% hydrogen peroxide (H2O2) for 15 min. Sections were 
washed with phosphate-buffered saline (PBS) and protein 
blocking were performed using avidin for 15 min. Sections 
were washed with PBS and endogenous biotins in tissue were 
blocked using biotin for 15 min. After washing with PBS, 
sections were incubated with the respective diluted primary 
antibodies (BRCA1) antibody diluted 1:100 for 60 minutes. 
Excess antibodies were washed off with PBS and secondary 
antibodies (LINK) were applied on section for 15 minutes. 
Sections were washed and the (LABEL) which is the horse-
radish peroxidase (HRP) were applied on the sections for 
15 minutes. A working DAB solution was made up by mixing 
1 drop (20 µ) of the DAB chromogen to 1 mL of the DAB 
substrate. The working solution was applied on sections 
after washing off the HRP with PBS for at least 5 min. The 
brown reactions begin to appear at the moment especially 
for a positive target. Excess DAB solution and precipitate 
were washed off with water. Sections were counterstained 
with hematoxylin for at least 2 min. Sections were then de-
hydrated in alcohol, cleared in xylene and mounted in DPX. 
Cells with specific brown colors in the cytoplasm, cell 
membrane or nuclei depending on the antigenic sites are 
considered to be positive. The hematoxylin-stained cells 
without any form of brown colors were scored negative. 
Non-specific binding/brown artifacts on cells and connective 
tissue are disregarded. For testicular cells, Sertoli cells were 
characterized by their large irregularly shaped nuclei on the 
basal layer of the seminiferous epithelium; myoid cells by 
their elongated nuclei around the periphery of the tubule; 
and Leydig cells by their round nuclei in the interstitial 
tissue. Assessment for androgen receptors was performed 
according to the following semi-quantitative scale: (–) 
negative; (+) weakly positive; (++) positive; and (+++) 
strongly positive [40].
Measurement of serum testosterone concentration. Testos-
terone was determined in duplicate, using the Testosterone 
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Enzyme Immunoassay kit (Assay Design Inc., Ann Arbour, 
MI, USA) according to the manufacturer’s instruction.
Statistical analysis. All continuous variables were collected, 
analyzed and expressed as mean ± standard deviation (SD). 
Statistical comparison of the differences between the control 
and experimental groups was performed with GraphPad In-
Stat Software (version 6.00, GraphPad Software, San Diego, 
CA, USA), using one-way analysis of variance (ANOVA) fol-
lowed by Turkey-Kramer multiple comparison test. P < 0.05 
was considered statistically significant.
results
Mortality
One animal died in the course of the experiment in 
the diabetic group treated with HAART.
Food and fluid intake and weight changes
Diabetic animals exhibited many symptoms commonly 
associated with diabetes (e.g. polyuria, polydipsia and 
diarrhea). Food intake was not different, but a signif-
icantly (p < 0.001) higher fluid intake was observed 
in all the diabetic groups compared with the negative 
control group (data not shown). The final body mass 
of rats in all groups were higher than the initial weight. 
Percentage change in body weight of all groups was 
significantly (p < 0.001) lower in groups G and H 
when compared with negative control (group A). 
Similarly, there were significant decline in body 
mass of rats treated with HAART + melatonin 
(p < 0.0001) (Table 1).
Serum concentrations of testosterone
Serum testosterone levels of the diabetic animals in 
groups (B, C through H) were signiﬁcantly (p < 0.0001) 
reduced compared with the normoglycemic control 
group (Table 2). The level of testosterone was not 
reversed by the administration of HH compared 
with the normoglycemic and diabetic control groups 
(p < 0.001 and p < 0.001, respectively; Table 2).
Histopathological examination of testes
Varying degree of collagen fibers deposition was ob-
served in the testes of diabetic animals (Suppl. Fig. 1B–H). 
The area percent showed unequal collagen distribu-
tion as compared with the normoglycemic control 
animals, which is presented with normal morphology 
with all generations of germ cells in the stages of 
the seminiferous epithelium cycle (Suppl. Fig. 1A). 
In addition, the testis of the diabetic control and all 
STZ-treated rats showed varying irregularities in the 
structure of seminiferous tubules, lined with disor-
ganized germinal epithelium and the intervening 
interstitial connective tissue. This deformity is more 
pronounced in the animals treated with HAART 
alone, as many tubules were necrotized with denud-
ed/detached spermatogenic cells from basal lamina 
(Suppl. Fig. 1C). In testicular sections of groups 
D and E, many tubules were extensively atrophied 
with only lining basement membrane remaining and 
interstitial spaces that were sparsely populated with 
cellular components (Suppl. Fig. 1D–E).
The expression of androgen receptors  
in the testes of control and experimental rats 
Immunolocalization of ARs in the wall of seminifer-
ous tubules of normoglycemic rat testis was found in 
the cytoplasm and nuclei of Sertoli cells. Expression 
of ARs was also observed in the nuclei of peritubular 
myoid and Leydig cells (Fig. 1A, Table 2). As shown in 
Figure 1B–H, there was a change in the pattern of ARs 
table 1. Body and testis mass of control and experimental rats
treatment initial body mass [g] final body mass [g] Body mass change (%) testis mass [g] testis/body mass
a Control 173.8 ± 9.2 289.8 ± 23.4 66.7 3.1 ± 0.2 1.10
B D-control 209.1 ± 14.2 270.6 ± 60.8 29.4 3.0 ± 0.3 1.10
C HAART 213.3 ± 14.3 268.3 ± 40.9 25.8 3.2 ± 0.4 1.10
d HH100 196.3 ± 18.6 280.5 ± 53.7 42.9 3.2 ± 0.2 1.10
E HH200 187.6 ± 20.7 242.4 ± 50.2 29.2 3.3 ± 0.4 1.13
f HAART + Mel 181.1 ± 19.8 231.3 ± 59.1 27.7 2.0 ± 1.2ab 0.80ab
g HAART + HH100 186.9 ± 56.4 214.3 ± 26.4 14.7
a 3.0 ± 0.4 1.14
h HAART + HH200 186.8 ± 17.5 213.0 ± 52.1 14.1
a 2.8 ± 0.5 1.13
Data are shown as the mean ± SD; p < 0.0001ab vs. group Aa and p < 0.05 vs. group Bb (Turkey-Kramer multiple range post-hoc test). Abbrevia-
tions: D-control — diabetic-control; HAART — highly active antiretroviral therapy; HH100 — Hypoxis hemerocallidea, 100 mg/day; HH200 — Hypoxis 
hemerocallidea 200 mg/day; Mel — melatonin.
154 Onanuga O. Ismail et al.
©Polish Society for Histochemistry and Cytochemistry
Folia Histochem Cytobiol. 2017
10.5603/FHC.a2017.0016
www.fhc.viamedica.pl
table 2. Serum testosterone concentrations and summary of receptor localization in the rat testis presented as intensity of 
immunostaining
group treatment testosterone [nmol/l] ar
Sertoli cells leydig cells Myoid cells germ cells
a Control 20.1 ± 6.8 ++ +++ +++ –
B D-control 2.5 ± 2.2a + + + –
C HAART-d 6.5 ± 6.3a + + – –
d HH100 4.6 ± 2.3
a + + + –
E HH200 2.4 ± 2.7
a ++ + + –
f HAART + Mel 0.1 ± 0.1ab + + + –
g HAART + HH100 0.3 ± 0.1
ab ++ + + +*
h HAART + HH200 0.4 ± 0.2ab ++ ++ + +*
Data are shown as the mean ± SD; p < 0.0001ab vs. Group Aa and Bb, p < 0.001 vs. Group Eb (Turkey-Kramer multiple range post-hoc test). Intensity 
of immunostaining scored as negative (–), weak positive (+), moderate positive (++) or strong positive (+++). *III/IV stages of the seminiferous 
epithelium cycle as defined by two independent observers. Abbreviations as for Table 1, AR — androgen receptor. 
figure 1. Immunoexpression of androgen receptor (AR) in the testis of control and experimental rats. a. Control group; 
B. Rat with streptozotocin-induced diabetes (diabetic group); C. Diabetic rats on HAART regimen; d. Diabetic rats treated 
with 100 mg/day of HH; E. Diabetic rats treated with 200 mg/day of HH; f. Diabetic rats on HAART treated with melatonin; 
g. Diabetic rats on HAART treated with 100 mg/day of HH; h. Diabetic rats on HAART treated with 200 mg/day of HH. 
Symbols: black arrow — nuclei of Sertoli cell; blue arrows — myoid cells; green arrows — Leydig cells. Abbreviations as in 
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expression in the testes of diabetic control and all HH 
alone, HAART + melatonin, HH + HAART-treated 
animals (Table 2). The expression was almost negative 
in the testis of diabetic control (group B) and those 
treated with HAART alone (Fig. 1B–C). Positive re-
action was present not only in the Sertoli cells, but also 
in the cytoplasm of spermatogonia and spermatocytes 
in III/IV stages of the seminiferous epithelium cycle 
of the animals treated with HAART concomitantly 
with Hypoxis of both dosages (Table 2). Germ cells of 
the other stages of the seminiferous epithelium cycle 
did not show immunoreactivity for AR. Expression 
of ARs was also observed in the nuclei of myoid cells 
and the nuclei of Leydig cells (Fig. 1A–B, Table 2). 
In control slides, no AR-positive cells were detected 
when the primary antibody was omitted.
discussion
The use of medicinal herbs, a principal component 
of traditional medicine, predates the emergence of 
HIV/AIDS, and there is widespread consumption of 
herbal products for the management of HIV/AIDS 
either as complementary or alternative medicine [29].
The current study revealed that diabetic damage 
resulting from streptozotocin-nicotinamide-induction 
in the era of HAART can affect not only the morphol-
ogy but also the expression of androgen receptors in 
the testis of rats. In addition, the examined serum 
testosterone level was significantly altered. HAART 
with HH induced negative observational changes 
in the body weight of experimental animals, mostly 
marked in the diabetic + HAART + HH (100 and 
200 mg/kg) animals. While loss of weight may be 
associated with induction of diabetes, initiation of 
HAART may as well contribute to the low pace of 
weight gain due to other metabolic activities relative 
to lipid and sugar [41].
Diabetes mellitus is characterized by absolute 
or relative deficiencies in insulin secretion and/or 
insulin action associated with chronic hyperglycemia 
and disturbances of carbohydrate, lipid and protein 
metabolism. Testicular cells, specifically Sertoli cells 
(SCs), take up extracellular glucose via specific glu-
cose transporters (GLUTs), which is then oxidized to 
pyruvate and promptly reduced to lactate by lactate 
dehydrogenase (LDH), with a concomitant oxida-
tion of NADH. Once produced, lactate is exported 
through the monocarboxylate transporter 4 (MCT4) 
to the intratubular fluid to become available for the 
developing germ cells. Thus, SCs and germ cells 
establish a tight metabolic cooperation that is highly 
dependent on glucose uptake and lactate production 
[22, 42]. From the physiological point of view the 
metabolism of carbohydrates, especially glucose, is 
vital for male reproductive health, so the maintenance 
of testicular glucose metabolism homeodynamics is 
of particular relevance; otherwise spermatogenesis 
is arrested [43]. Hence, the full enlightenment of 
testicular glucose metabolism and the molecular 
mechanisms that control it is of extreme importance, 
since alterations in these mechanisms may be the basis 
of male infertility [42].
While blood glucose levels remain elevated in this 
present study at the dosages used, previous reports [44] 
show that the methanolic extract of Hypoxis hemero-
callidea at very high dose of 800 mg/kg and above was 
found to reduce blood glucose concentrations in nor-
mal and diabetic rats by 35% and 55%, respectively, 
for few hours as compared with anti-diabetic effects 
of glibenclamide [44]. The associated physiological 
responses to diabetic states (including excessive loss 
of fluid with consequent weight loss) are reflected in 
our data, of which adjuvant HH was unable to restore. 
This perhaps raises concern on the antihyperglycemic 
property or beneficial use of HH extracts by the indig-
enous communities for the treatment of adult-induced 
diabetes mellitus. Serum testosterone levels also re-
mained diminished in all the diabetic rats. Reduced 
serum testosterone in diabetic rats was attributed in 
previous studies to neuroendocrine dysfunction and 
the absence of the stimulatory effect of insulin on the 
Leydig cells [19, 45].
In the present study, the seminiferous tubules 
basement membrane of the experimental groups 
showed thickening, which was similar to Santoro et al. 
report [46]. More so, observation of the seminiferous 
tubules with detached, disorganized germ cells and 
dislocation of spermatozoa to positions that are close-
ly related to the basement membrane with decreased 
seminiferous epithelial height in group administered 
with HAART were also observed. As earlier report-
ed, the results may be due to the rapid disruption of 
Sertoli-germ cells interactions due to disturbance of 
normal supportive function of Sertoli cells as a result 
to exposure to some drugs and injurious toxicants [47]. 
The physical interaction ultimately leads to sloughing 
of the germ cells from the seminiferous epithelium.
Data from this study showed that diabetes and 
HAART created extensive structural changes in 
the seminiferous tubules of the animals which were 
neither ameliorated with Hypoxis nor melatonin treat-
ment. The reduction in spermatogenic cells seen is 
similar to atrophic seminiferous tubules with denuded 
sperm cells which are all consequences of a diabetic 
pathology [48]. Derangements in the process of sper-
matogenesis seen in diabetic conditions have been 
previously documented [45, 49] and this applies also 
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to the testicular disruption [50]. Diabetes is known to 
alter basement membrane thickness which ultimately 
causes declines in sperm production (count) and 
morphology of the tubules [51]. Explanation for this 
is understandable by the fact that due to inadequate 
insulin production, Sertoli and Leydig cell functions 
deteriorate in addition to weakening of spermatogen-
esis consequent on reduced FSH levels [52].
Androgen receptor (AR) is a member of a large 
family of ligand-activated nuclear receptors and is 
highly expressed in the testes, particularly in Sertoli 
cells [53]. Sertoli cells are thought to be the major 
cellular target for the testosterone signaling that is 
required to support male germ cell development and 
survival [54]. In the current study, ARs are localized 
to the nuclei of Sertoli cells, peritubular myoid cells, 
Leydig cells and the cytoplasm of spermatogonia and 
spermatocytes in III/IV stages of the seminiferous 
epithelium cycle of the animals treated with HAART 
concomitantly with Hypoxis of both dosages. This 
finding is in accordance with previous ones where 
absence of AR immunoexpression in germ cells and 
intense staining in Sertoli cells (SCAR) was thought 
to be the major cellular target for the testosterone 
signaling that is required to support male germ 
cell development and survival [53, 54]. Male mice 
lacking SCARs were reported to be associated with 
infertility, as spermatogenesis rarely progress beyond 
meiosis [55, 56]. Several spermatogenic disorders are 
associated with impaired androgenic stimulation of 
Sertoli cells; thus, low levels of the AR are likely to be 
involved in spermatogenic disorders [57] or incorrect 
androgen-sensitive course of spermatogenesis [58].
Testosterone also plays important role in the final 
maturation of Sertoli cells [59], and both testosterone 
and FSH have additive effects on SCAR expression [57]. 
As reported in this study, testosterone level was 
significantly reduced in all HAART and HH treated 
animals. More so, rather than FSH stimulation, AR 
expression has been shown to be primarily dependent 
on the testosterone level [60], as AR knockout affects 
the ability of Sertoli cells to support maturing germ 
cells, resulting in spermatogenesis arrest before the 
first meiotic division and during the transition from 
round to elongated spermatids, causing progressive 
loss of fertility [55].
Furthermore, the administration of melatonin 
results in a rapid rise in blood melatonin concen-
trations and due to its lipophilic and hydrophilic 
properties [48], it passes rapidly through all biological 
membranes and enters the cells and their subcellular 
compartments. This is an advantage for melatonin 
over some other antioxidants that penetrate cells 
more slowly. However, we observed that melatonin 
administered at the dose (5 mg/kg) in this protocol did 
not mitigate the testicular dysfunction observed. This 
probably may be due to melatonin-HAART interac-
tion which suppresses its efficacy as an antioxidant.
In addition, it was observed that the diabetic con-
trol animals as well as all the treated animals showed 
more of cytoplasmic instead of nuclear AR expression. 
The findings could be explained in the light of pre-
vious studies — in the presence of androgens AR is 
normally localized in the nucleus, while in the absence 
of androgens the receptors migrate from the nucleus 
back into normal cytoplasm [61]. Therefore, altera-
tions in normal AR expression in these cells would be 
an indicator of the hormonal status of the cells [62].
In conclusion, our results further suggest the 
inability of Hypoxis or melatonin to ameliorate tes-
ticular dysfunction observed in diabetic rats. Further 
investigation on alternate dosages is on-going in our 
laboratory to ascertain the claimed anti-hyperglycemic 
property of the Hypoxis, which will be essential to 
provide new insights into the effects of HAART-asso-
ciated T2DM on testicular integrity and male fertility.
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